These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34550227)

  • 1. Atrial Fibrillation Diagnosis using ECG Records and Self-Report in the Community: Cross-Sectional Analysis from ELSA-Brasil.
    Santos IS; Lotufo PA; Brant L; Pinto Filho MM; Pereira ADC; Barreto SM; Ribeiro AL; Thomas GN; Lip GYH; Bensenor IM
    Arq Bras Cardiol; 2021 Sep; 117(3):426-434. PubMed ID: 34550227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular Health and Atrial Fibrillation or Flutter: A Cross-Sectional Study from ELSA-Brasil.
    Santos IS; Lotufo PA; Goulart AC; Brant LCC; Pinto Filho MM; Pereira AC; Barreto SM; Ribeiro ALP; Thomas GN; Lip GYH; Bensenor IM; ; Arasalingam A; Beane A; Bensenor IM; Brocklehurst P; Cheng KK; El-Bouri W; Feng M; Goulart AC; Greenfield S; Guo Y; Guruparan M; Gusso G; Gooden TE; Haniffa R; Humphreys L; Jolly K; Jowett S; Kumarendran B; Lancashire E; Lane DA; Li X; Lip Co-Pi GYH; Li YG; Lobban T; Lotufo PA; Manseki-Holland S; Moore DJ; Nirantharakumar K; Olmos RD; Paschoal E; Pirasanth P; Powsiga U; Romagnolli C; Santos IS; Shantsila A; Sheron VA; Shribavan K; Szmigin I; Subaschandren K; Surenthirakumaran R; Tai M; Neil Thomas Co-Pi G; Varella AC; Wang H; Wang J; Zhang H; Zhong J
    Arq Bras Cardiol; 2022 Sep; 119(5):724-31. PubMed ID: 36169453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stroke at baseline of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil): a cross-sectional analysis.
    Abreu FG; Goulart AC; Birck MG; Benseñor IM
    Sao Paulo Med J; 2018; 136(5):398-406. PubMed ID: 30570091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in stroke prevention in atrial fibrillation in French primary care. Results of the AFIGP (Atrial Fibrillation In General Practice) database.
    Sabouret P; Depret-Bixio L; Cotte FE; Marie P; Bedira N; Blin P
    Clin Res Cardiol; 2014 Nov; 103(11):887-93. PubMed ID: 24830515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulant Therapy in Atrial Fibrillation for Stroke Prevention: Assessment of Agreement Between Clinicians' Decision and CHA2DS2-VASc and HAS-BLED Scores.
    Balaghi-Inalou M; Parsa SA; Gachkar L; Andalib S
    High Blood Press Cardiovasc Prev; 2018 Mar; 25(1):61-64. PubMed ID: 29076078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of undiagnosed atrial fibrillation and of that not being treated with anticoagulant drugs: the AFABE study.
    Clua-Espuny JL; Lechuga-Duran I; Bosch-Princep R; Roso-Llorach A; Panisello-Tafalla A; Lucas-Noll J; López-Pablo C; Queralt-Tomas L; Giménez-Garcia E; González-Rojas N; Gallofré López M
    Rev Esp Cardiol (Engl Ed); 2013 Jul; 66(7):545-52. PubMed ID: 24776203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation.
    Lip GY; Rushton-Smith SK; Goldhaber SZ; Fitzmaurice DA; Mantovani LG; Goto S; Haas S; Bassand JP; Camm AJ; Ambrosio G; Janský P; Al Mahmeed W; Oh S; van Eickels M; Raatikainen P; Steffel J; Oto A; Kayani G; Accetta G; Kakkar AK;
    Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2 Suppl 1):S12-20. PubMed ID: 25714828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is an Oral Anticoagulant Necessary for Young Atrial Fibrillation Patients With a CHA2DS2-VASc Score of 1 (Men) or 2 (Women)?
    Hung Y; Chao TF; Liu CJ; Tuan TC; Lin YJ; Chang SL; Lo LW; Hu YF; Liao JN; Chung FP; Lin WY; Lin WS; Cheng SM; Chen TJ; Lip GY; Chen SA
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27702803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of atrial fibrillation and flutter temporal pattern on anticoagulation and return visits to the emergency department: A historic cohort of 1112 patients.
    Almeida ED; Ley ALG; de Lima GG; Saffi MAL; Leiria TLL
    J Electrocardiol; 2019; 56():109-114. PubMed ID: 31376745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
    Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Adherence to Guideline-Directed Antithrombotic Therapy for Atrial Fibrillation at Hospital Discharge.
    Dupree L; DeLosSantos M; Smotherman C
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):502-508. PubMed ID: 29806486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHA
    Kim TH; Yang PS; Kim D; Yu HT; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
    Stroke; 2017 Nov; 48(11):2984-2990. PubMed ID: 28939672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of CHADS2 versus CHA2DS2-VASc for predicting stroke and thromboembolism in atrial fibrillation patients independent of anticoagulation.
    Zhu WG; Xiong QM; Hong K
    Tex Heart Inst J; 2015 Feb; 42(1):6-15. PubMed ID: 25873792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incremental yield of ECG screening repeated annually over 4 years in an adult Japanese population without prior atrial fibrillation: a retrospective cohort study.
    Nagata Y; Yamagami T; Nutbeam D; Freedman B; Lowres N
    BMJ Open; 2020 Jul; 10(7):e035650. PubMed ID: 32690510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inadequate stroke prevention in Korean atrial fibrillation patients in the post-warfarin era.
    Choi EJ; Lee IH; Je NK
    Int J Cardiol; 2016 Oct; 220():647-52. PubMed ID: 27393842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stroke Risk Status, Anticoagulation Treatment, and Quality-of-Life in Chinese Patients with Atrial Fibrillation: China Registry of Atrial Fibrillation (CRAF).
    Sun Y; Zhu J; Ma C; Liu S; Yang Y; Hu D
    Cardiovasc Ther; 2019; 2019():7372129. PubMed ID: 31772614
    [No Abstract]   [Full Text] [Related]  

  • 17. CHA
    Parsons C; Patel SI; Cha S; Shen WK; Desai S; Chamberlain AM; Luis SA; Aguilar MI; Demaerschalk BM; Mookadam F; Shamoun F
    Mayo Clin Proc; 2017 Mar; 92(3):360-369. PubMed ID: 28259228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and treatment of atrial fibrillation in UK general practice from 2000 to 2016.
    Adderley NJ; Ryan R; Nirantharakumar K; Marshall T
    Heart; 2019 Jan; 105(1):27-33. PubMed ID: 29991504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and safety of rivaroxaban vs. warfarin in non-valvular atrial fibrillation patients with a non-sex-related CHA2DS2-VASc score of 1.
    Coleman CI; Turpie AGG; Bunz TJ; Eriksson D; Sood NA; Baker WL
    Eur Heart J Cardiovasc Pharmacother; 2019 Apr; 5(2):64-69. PubMed ID: 30020424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stroke risk in hypertrophic cardiomyopathy patients with atrial fibrillation: a nationwide database study.
    Hsu JC; Huang YT; Lin LY
    Aging (Albany NY); 2020 Nov; 12(23):24219-24227. PubMed ID: 33226371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.